Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 0.62%10.84B | 2.36%40.03B | 0.76%29.92B | 0.72%20.46B | 2.49%10.77B | 7.19%39.11B | 10.30%29.69B | 12.73%20.31B | 11.49%10.51B | 0.31%36.49B |
Operating revenue | 0.62%10.84B | 2.36%40.03B | 0.76%29.92B | 0.72%20.46B | 2.49%10.77B | 7.19%39.11B | 10.30%29.69B | 12.73%20.31B | 11.49%10.51B | 0.31%36.49B |
Other operating revenue | ---- | 1.01%49.36M | ---- | 36.71%37.69M | ---- | 0.13%48.87M | ---- | -16.87%27.57M | ---- | -37.49%48.81M |
Total operating cost | -2.60%8.75B | 0.35%35.21B | -0.68%25.48B | -1.36%17.23B | -1.05%8.98B | 9.34%35.08B | 11.08%25.66B | 14.54%17.46B | 17.28%9.08B | 1.09%32.09B |
Operating cost | -1.65%7.42B | 0.42%28.86B | -0.66%21.42B | -1.70%14.46B | -1.12%7.54B | 6.92%28.74B | 11.59%21.56B | 15.01%14.71B | 15.82%7.63B | 1.45%26.88B |
Operating tax surcharges | -3.10%53.39M | 15.33%243.12M | 7.26%168.05M | 10.32%119.55M | 15.00%55.09M | 0.15%210.8M | 1.32%156.68M | 0.74%108.37M | -8.36%47.91M | 9.27%210.49M |
Operating expense | -13.23%1.07B | -2.26%4.88B | -1.42%3.31B | 1.73%2.3B | 2.71%1.23B | 19.84%4.99B | 8.58%3.35B | 12.32%2.26B | 25.35%1.2B | 6.91%4.17B |
Administration expense | -3.12%156.4M | -1.98%1.04B | -10.06%499.58M | -4.95%327.41M | -1.85%161.44M | 26.95%1.06B | 3.75%555.45M | -7.10%344.44M | -18.89%164.48M | -22.76%833.78M |
Financial expense | 86.31%-9.2M | 40.00%-155.56M | 32.87%-128.38M | -22.29%-129.62M | -142.08%-67.22M | 24.39%-259.24M | 9.72%-191.25M | 35.28%-105.99M | 75.03%-27.77M | -32.75%-342.88M |
-Interest expense (Financial expense) | -45.73%6.19M | 27.37%63.18M | 69.88%43.59M | 47.08%27.65M | 9.92%11.4M | -26.90%49.6M | -51.46%25.66M | -59.19%18.8M | -49.51%10.37M | 31.34%67.85M |
-Interest Income (Financial expense) | 75.46%-20.21M | 29.94%-221.21M | 10.03%-188.53M | -41.76%-162.71M | -59.94%-82.36M | 15.64%-315.76M | 21.94%-209.54M | 49.11%-114.78M | 64.19%-51.49M | -10.29%-374.31M |
Research and development | 4.96%60.12M | 0.42%337.41M | -1.11%216.18M | 2.23%148.04M | -10.62%57.28M | -0.21%336.01M | 5.17%218.61M | 12.59%144.82M | 22.48%64.09M | 1.62%336.72M |
Credit Impairment Loss | 34.02%-90.59M | 70.74%-39.93M | -30.48%-130.56M | -10.82%-82.76M | -85.34%-137.3M | 81.17%-136.46M | 85.97%-100.07M | 88.85%-74.68M | 33.63%-74.08M | -163.85%-724.55M |
Asset Impairment Loss | -678.05%-23.11M | -56.95%-91.23M | -207.82%-14.01M | -118.83%-3.58M | -21.13%4M | 91.25%-58.13M | 102.09%12.99M | 103.20%19.01M | --5.07M | -363.86%-664.34M |
Other net revenue | 28.94%165.24M | 10.37%885.12M | -31.39%576.49M | -5.24%442.08M | -56.86%128.15M | 177.87%801.96M | 165.54%840.19M | 141.92%466.54M | 149.20%297.03M | 10.36%-1.03B |
Fair value change income | 309.82%40.96M | 10.74%136.84M | -118.11%-18.77M | -91.34%4.6M | -118.93%-19.52M | 119.93%123.57M | 113.79%103.65M | 112.74%53.09M | 119.67%103.15M | 67.87%-619.9M |
Invest income | -8.87%222.56M | -0.27%776.94M | -2.57%685.14M | 13.27%477.5M | 0.75%244.23M | -10.27%779.01M | -2.31%703.22M | -20.92%421.54M | 2,693.58%242.4M | -16.87%868.2M |
-Including: Investment income associates | -12.43%233.25M | 23.19%774.28M | 8.07%700.91M | 13.33%506.63M | -0.32%266.35M | -14.16%628.53M | 7.40%648.57M | 7.51%447.05M | 3,018.68%267.21M | 3,570.33%732.23M |
Asset deal income | 112.36%81.79K | -95.39%490.65K | -127.09%-1.48M | -129.47%-1.59M | 50.68%-661.9K | 79.22%10.65M | 558.41%5.48M | 378.21%5.4M | 42.08%-1.34M | 33.58%5.94M |
Other revenue | -59.02%15.33M | 22.44%102.01M | -51.12%56.17M | 13.62%47.92M | 71.35%37.41M | -20.45%83.32M | 31.50%114.91M | 18.46%42.18M | -16.08%21.84M | -29.84%104.73M |
Operating profit | 17.59%2.26B | 18.24%5.71B | 2.82%5.01B | 10.84%3.67B | 10.86%1.92B | 43.28%4.83B | 92.10%4.87B | 99.83%3.31B | 59.61%1.73B | -3.27%3.37B |
Add:Non operating Income | 116.06%5.04M | 26.56%15.48M | 106.09%11.7M | 121.28%4.43M | -11.55%2.33M | -9.97%12.23M | 39.63%5.68M | 5.46%2M | 10.50%2.64M | 33.89%13.59M |
Less:Non operating expense | 563.41%4.36M | 71.40%42.39M | -38.94%9.34M | -60.59%4.76M | -88.39%657.58K | 214.37%24.73M | 264.42%15.29M | 267.91%12.07M | 120.47%5.66M | -42.47%7.87M |
Total profit | 17.52%2.26B | 17.99%5.68B | 3.07%5.01B | 11.16%3.67B | 11.15%1.92B | 42.67%4.82B | 91.73%4.86B | 99.39%3.3B | 59.36%1.73B | -3.01%3.38B |
Less:Income tax cost | 48.87%328.47M | 31.95%917.65M | -7.78%683.55M | 1.06%482.07M | 4.36%220.65M | 29.60%695.45M | 86.96%741.26M | 64.35%477.02M | 17.29%211.43M | -21.55%536.59M |
Net profit | 13.45%1.93B | 15.63%4.77B | 5.03%4.33B | 12.87%3.19B | 12.09%1.7B | 45.14%4.12B | 92.62%4.12B | 106.84%2.83B | 67.75%1.52B | 1.53%2.84B |
Net profit from continuing operation | 13.45%1.93B | 15.63%4.77B | 5.03%4.33B | 12.87%3.19B | 12.09%1.7B | 45.14%4.12B | 92.62%4.12B | 106.84%2.83B | 67.75%1.52B | 1.53%2.84B |
Less:Minority Profit | -147.08%-7.13M | -38.65%17.66M | 406.00%2.97M | 164.64%1.13M | -27.38%-2.89M | 117.91%28.78M | 99.41%-971.39K | 98.69%-1.75M | 79.04%-2.26M | -2,114.89%-160.72M |
Net profit of parent company owners | 13.67%1.93B | 16.02%4.75B | 4.93%4.33B | 12.76%3.19B | 12.12%1.7B | 36.41%4.09B | 78.90%4.12B | 88.47%2.83B | 66.01%1.52B | 7.00%3B |
Earning per share | ||||||||||
Basic earning per share | 13.68%1.08 | 16.16%2.66 | 4.76%2.42 | 13.29%1.79 | 11.76%0.95 | 20.53%2.29 | 50.98%2.31 | 43.64%1.58 | 19.72%0.85 | -14.03%1.9 |
Diluted earning per share | 13.68%1.08 | 16.16%2.66 | 5.22%2.42 | 13.29%1.79 | 11.76%0.95 | 20.53%2.29 | 51.32%2.3 | 44.95%1.58 | 19.72%0.85 | -12.84%1.9 |
Other composite income | 87.27%-122.54K | 38.48%-13.44M | 81.70%-5.08M | 72.10%-8.02M | -114.68%-962.93K | 73.16%-21.85M | 72.03%-27.76M | 30.44%-28.75M | 199.21%6.56M | -3,451.25%-81.41M |
Other composite income of parent company owners | 102.82%28.47K | 45.34%-11.73M | 84.67%-4.92M | 69.61%-8.37M | -121.09%-1.01M | 69.62%-21.45M | 64.22%-32.08M | 26.29%-27.54M | 181.32%4.79M | -2,990.46%-70.6M |
Other composite income of minority owners | -425.45%-151.01K | -331.95%-1.72M | -103.78%-163.38K | 128.66%347.43K | -97.39%46.4K | 96.33%-397.3K | 145.07%4.32M | 69.51%-1.21M | 343.71%1.78M | -81,460.44%-10.81M |
Total composite income | 13.50%1.93B | 15.92%4.75B | 5.61%4.32B | 13.74%3.18B | 11.55%1.7B | 48.63%4.1B | 100.63%4.09B | 111.12%2.8B | 69.72%1.52B | -1.47%2.76B |
Total composite income of parent company owners | 13.74%1.93B | 16.34%4.74B | 5.63%4.32B | 13.57%3.18B | 11.70%1.7B | 38.96%4.07B | 84.69%4.09B | 91.40%2.8B | 67.62%1.52B | 4.39%2.93B |
Total composite income of minority owners | -156.44%-7.28M | -43.83%15.94M | -16.13%2.81M | 149.93%1.48M | -480.42%-2.84M | 116.55%28.38M | 101.92%3.35M | 97.85%-2.96M | 95.76%-489.07K | -2,259.58%-171.53M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.